How Companies Make Money
Eli Lilly Cuts Its Prices. It Earns on Selling Far More Doses While the Patent Holds.
Eli Lilly earns on selling far more doses of one compound, tirzepatide (Mounjaro and Zepbound), at lower prices while its patent is in force. Watch whether volume grows faster than price falls.